Minimally invasive clot removal for lobar brain bleeds
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests a minimally invasive procedure using a special clot-busting medicine (tenecteplase) for a certain type of brain bleed. It aims to see if this approach improves recovery compared to standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old.
- Your symptoms started within the last 24 hours.
- The bleed is in the outer part of the brain (lobar), not deep areas, and is between 30 and 50 ml in size.
- You are not on blood thinners (like warfarin, Eliquis, Xarelto, or Plavix).
- You have not had a prior brain bleed or aneurysm.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if surgery to remove a large brain bleed (called lobar ICH) can help patients recover. It's for people who can have surgery within 16 hours of symptoms starting.
This trial tests a minimally invasive procedure to remove deep brain bleeds using a special puncture guided by brain imaging, combined with a clot-dissolving drug called tenecteplase. It may help reduce damage from the bleed and improve recovery.
This trial tests a less invasive surgery to remove small blood clots (20–30 ml) in the basal ganglia, a deep part of the brain. It may help people who are awake but have a reduced level of consciousness after a recent brain bleed.
This trial tests a clot-busting drug (rhTNK-tPA) to remove blood from the ventricles (fluid spaces deep in the brain) after a spontaneous brain bleed. It may help patients whose ventricles are blocked by a large clot, reducing pressure and improving recovery.
This trial tests a minimally invasive surgery to remove blood clots deep in the brain after a spontaneous bleed. It may help patients with moderate to large bleeds who are at least 18 and up to 80 years old.
This trial studies whether a minimally invasive, image-guided endoscopic procedure can remove blood after a specific type of brain bleed. It may help reduce symptoms and improve outcomes compared with standard care, but you must meet timing and medical criteria.
Hear when a new Intracerebral Hemorrhage Lobar trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.